What's Happening?
Amperos Health has successfully raised $16 million in a Series A funding round led by Bessemer Venture Partners, with additional participation from Uncork Capital and Neo. This funding follows a previous $4.2 million seed round in June 2025. The company
has developed an AI-native, end-to-end denial management platform designed to streamline the healthcare revenue cycle management (RCM) process. The platform utilizes agentic AI, which includes state-of-the-art language models with computer and voice capabilities, to independently manage insurance claims, navigate payer portals, and submit corrected claims. This technology aims to address the challenges of high denial rates and staffing shortages in the healthcare industry by automating complex tasks traditionally handled by human coders.
Why It's Important?
The introduction of Amperos Health's AI platform is significant for the healthcare industry, which faces substantial financial losses due to denied claims. In 2024, approximately 12% of healthcare claims were denied, resulting in a $262 billion loss for providers. By automating the denial management process, Amperos Health's platform can potentially reduce costs by up to 50% and increase claim recovery rates by 20% to 22% compared to traditional methods. This innovation not only promises financial relief for healthcare providers but also allows existing staff to focus on more complex claims that require human judgment, thereby improving overall efficiency and effectiveness in the RCM process.
What's Next?
With the new funding, Amperos Health plans to expand its platform's capabilities and grow into other RCM workflows. The company aims to enhance its analytics capabilities and fill gaps in the RCM workforce, allowing healthcare providers to better manage high-complexity claims. As the platform continues to evolve, it is expected to adapt to changing payer behaviors and further improve claim recovery rates. The success of this platform could lead to broader adoption across the healthcare industry, potentially transforming how denial management is handled and providing a model for other sectors facing similar challenges.
